Characteristics Of Difficult-To-Treat Psoriatic Arthritis: A Comparative Analysis

被引:5
|
作者
Philippoteaux, Cecile [1 ,4 ]
Marty-Ane, Anne [1 ]
Cailliau, Emeline [2 ]
Labreuche, Julien [2 ]
Philippe, Peggy [1 ]
Cortet, Bernard [1 ]
Paccou, Julien [1 ]
Flipo, Rene-Marc [1 ]
Letarouilly, Jean-Guillaume [3 ]
机构
[1] Lille Univ Hosp, Rheumatol Dept, Lille, France
[2] Lille Univ Hosp, Biostat Dept, Lille, France
[3] Lille Univ, Lille Univ Hosp, Rheumatol Dept, FHU PRECISE, Lille, France
[4] Lille Univ Hosp, Roger Salengro Hosp, Rheumatol Dept, Ave Prof Emile Laine, F-59037 Lille, France
关键词
Psoriatic arthritis; difficult-to-treat; bDMARD; tsDMARD; RHEUMATOID-ARTHRITIS; DEPRESSION; BIOLOGICS; ANXIETY; UPDATE;
D O I
10.1016/j.semarthrit.2023.152275
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The EULAR task force recently published the difficult-to-treat rheumatoid arthritis (D2T RA) criteria, however, a definition of D2T patients in psoriatic arthritis (PsA) is still lacking. To date, we have little data concerning D2T PsA, especially in real-world. One of the limitations of the D2T RA EULAR definition is the absence of a temporal criterion. The primary endpoint of this work was to study the characteristics of D2T PsA patients using the EULAR definition. The second objective was to study a sub-group of patients with a predefined more stringent definition including a temporal criterion. Methods: A retrospective study was performed in a tertiary center. D2T PsA was defined as failure of >= 2 b/ tsDMARDs with different mechanism of action. Very D2T PsA was defined as failure of >= 2 b/tsDMARDs in less than 2 years of follow-up. D2T and Very D2T PsA patients were compared to nD2T PsA patients using statistical tests. Results: 150 PsA patients were included (from 2004 to 2015): 49 D2T PsA and 101 nD2T PsA. D2T PsA was associated with a higher prevalence of axial involvement (p=0.030), axial and/or peripheral structural damage (p=0.007) at baseline and more bDMARDs discontinuation due to poor dermatological control (p=0.005). There was no significant difference regarding comorbidities such as obesity, smoking status, fibromyalgia or depression. In multivariate analysis, peripheral structural damage at baseline was found to be a predictive factor for D2T PsA with an OR of 2.57 (1.16 to 5.69; p=0.020). 17 PsA (11.3%) patients were categorized as Very D2T PsA. When compared to nD2T group, proportion of obesity was higher (p=0.015) and axial involvement was more prevalent in the Very D2T group (p=0.020).Conclusion: D2T PsA patients had a higher prevalence of axial involvement, peripheral structural damage and therapeutic discontinuation due to poor dermatological control whereas Very D2T PsA patients were more likely obese with axial involvement. Very D2T PsA represent a minim proportion among patients when applying a more stringent definition. Pending the PsA D2T definition by the European and American societies, this study high-lights some characteristics that may help practitioners better identify D2T patients.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Characteristics of Difficult-To-Treat Psoriatic Arthritis: A Comparative Analysis
    Philippoteaux, Cecile
    Marty-Ane, Anne
    Cailliau, Emeline
    Philippe, Peggy
    Cortet, Bernard
    Paccou, Julien
    Flipo, Rene-Marc
    Letarouilly, Jean-Guillaume
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1560 - 1562
  • [2] CHARACTERISTICS OF DIFFICULT TO TREAT PSORIATIC ARTHRITIS: A COMPARATIVE ANALYSIS
    Philippoteaux, C.
    Marty-Ane, A.
    Martin, C.
    Philippe, P.
    Paccou, J.
    Cortet, B.
    Flipo, R. M.
    Letarouilly, J. G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1121 - 1121
  • [3] Upadacitinib in the treatment of difficult-to-treat psoriatic arthritis
    Graceffa, D.
    Sperati, F.
    Lora, V.
    Orsini, D.
    Spoletini, G.
    Bonifati, C.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024,
  • [4] Difficult-to-Treat Psoriatic Arthritis: A Conceptual Approach
    Fagni, Filippo
    Motta, Francesca
    Schett, Georg
    Selmi, Carlo
    [J]. ARTHRITIS & RHEUMATOLOGY, 2024, 76 (05) : 670 - 674
  • [5] CHARACTERISTICS OF DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS
    Takanashi, S.
    Kaneko, Y.
    Takeuchi, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 612 - 613
  • [6] Clinical Characteristics of Potential "Difficult-to-treat" Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort
    Perrotta, Fabio Massimo
    Scriffignano, Silvia
    Ciccia, Francesco
    Lubrano, Ennio
    [J]. RHEUMATOLOGY AND THERAPY, 2022, 9 (04) : 1193 - 1201
  • [7] Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort
    Fabio Massimo Perrotta
    Silvia Scriffignano
    Francesco Ciccia
    Ennio Lubrano
    [J]. Rheumatology and Therapy, 2022, 9 : 1193 - 1201
  • [8] Difficult-to-treat psoriatic arthritis: moving out of the rheumatoid arthritis shadow
    Siebert, Stefan
    Marzo-Ortega, Helena
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2024, 20 (03) : 135 - 136
  • [9] Difficult-to-treat psoriatic arthritis: moving out of the rheumatoid arthritis shadow
    Stefan Siebert
    Helena Marzo-Ortega
    [J]. Nature Reviews Rheumatology, 2024, 20 : 135 - 136
  • [10] CHARACTERISTICS OF PATIENTS WITH DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS IN FRANCE
    Hecquet, S.
    Combier, A.
    Steelandt, A.
    Pons, M.
    Wendling, D.
    Molto, A.
    Richard, C. Miceli
    Allanore, Y.
    Avouac, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 181 - 182